Literature DB >> 3640792

In vitro suppression of HTLV-III/LAV infectivity by a combination of acyclovir and suramin.

L Resnick, P D Markham, K Veren, S Z Salahuddin, R C Gallo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3640792     DOI： 10.1093/infdis/154.6.1027

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  6 in total

Review 1.  Treatment of human immunodeficiency virus infections.

Authors:  M S Hirsch; J C Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

2.  Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication.

Authors:  D L Romero; M Busso; C K Tan; F Reusser; J R Palmer; S M Poppe; P A Aristoff; K M Downey; A G So; L Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

3.  Anti-human immunodeficiency virus effects of dextran sulfate are strain dependent and synergistic or antagonistic when dextran sulfate is given in combination with dideoxynucleosides.

Authors:  M E Busso; L Resnick
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

4.  Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus.

Authors:  J C Lin; Z X Zhang; M C Smith; K Biron; J S Pagano
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

5.  Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.

Authors:  Andrea Lisco; Christophe Vanpouille; Egor P Tchesnokov; Jean-Charles Grivel; Angélique Biancotto; Beda Brichacek; Julie Elliott; Emilie Fromentin; Robin Shattock; Peter Anton; Robert Gorelick; Jan Balzarini; Christopher McGuigan; Marco Derudas; Matthias Götte; Raymond F Schinazi; Leonid Margolis
Journal:  Cell Host Microbe       Date:  2008-09-11       Impact factor: 21.023

Review 6.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.